Search

everythinglearnresearchcommunity

for

Search:↓

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Stem-cell therapy shows promise for skin conditions but needs more research.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Transplant success has improved with better immunosuppressive drugs and donor matching.

PRP is a safe natural treatment that improves skin by reducing wrinkles and enhancing texture for up to 4 months.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.